サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684425

呼吸器疾患検査の世界市場：製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Respiratory Disease Testing Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 322 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
呼吸器疾患検査の世界市場：製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

呼吸器疾患検査の市場規模は2024年に65億9,043万米ドルとなり、2025年から2032年にかけてCAGR 2.99％で拡大

呼吸器疾患検査の市場力学

感染性呼吸器疾患の蔓延とデジタル統合の高まりが市場需要を促進する見込み

呼吸器疾患検査市場は、呼吸器疾患の有病率の上昇や技術の進歩など、さまざまな要因が重なり、大幅な成長が見込まれています。喘息、慢性閉塞性肺疾患（COPD）、間質性肺疾患などの慢性呼吸器疾患は増加傾向にあります。世界保健機関（WHO）によると、COPDは世界の主要な死因の一つであり、喘息は世界で数億人が罹患しています。さらに、RT-PCRのような迅速検査法が一般用語となり、診断ラボはその能力を拡大しました。

さらに、分子診断学、ポリメラーゼ連鎖反応（PCR）検査、次世代シークエンシング（NGS）などの新しい技術は、呼吸器疾患の検出感度と特異性を向上させました。携帯可能で迅速な診断ツールが利用できるようになったことで、呼吸器疾患の検査がより身近になりました。これらの機器は、遠隔地や緊急時に特に有益です。人工知能（AI）と機械学習（ML）が診断プロセスに組み込まれ、スピードと精度が向上しています。AIを搭載したツールは、胸部X線やCTスキャンなどの画像検査の解釈を助けています。さらに、高度な診断ツールの高額な費用やヘルスケアへのアクセス格差が、遠隔医療や低コストの検査ソリューションのような技術革新を促し、成長をさらに促進しています。

呼吸器疾患検査市場：主な考察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約2.99%のCAGRで毎年成長すると予測されています。

製品別に見ると、X線画像の採用増加により、画像検査セグメントが2024年に最大市場シェアを示すと予測されました。

用途別では、結核の有病率の高さと診断の必要性から、結核分野が2024年に主要用途分野となりました。

エンドユーザー別では、X線装置のような高度な医療機器の導入が増加していることから、2024年には病院分野がエンドユーザー分野の首位となっています。

地域別では、喘息やその他の呼吸器疾患の有病率の高さから、北米が2024年の主要収益源となりました。

呼吸器疾患検査市場：セグメンテーション分析

呼吸器疾患検査の世界市場は、製品、用途、エンドユーザー、地域に基づいて区分されます。

製品別では、画像検査、血液ガス検査、呼吸器測定装置、その他の4つに分類されます。画像検査分野が市場を独占しています。X線装置や3Dイメージングプラットフォームのような高度なイメージング装置の高い導入が、このセグメントの成長を後押ししています。

市場は用途別に肺がん、結核、喘息、慢性閉塞性肺疾患（COPD）、その他の5つに分類されます。最も大きなシェアを占めるのは結核です。肺がんセグメントは、予防診断ケアの必要性から、予測期間中に最も速い速度で成長すると予測されます。

市場はエンドユーザー別に病院、臨床検査室、その他の3つに分類されます。エンドユーザー別では、病院分野が最大のシェアを占めています。呼吸器疾患の有病率の増加、高度な機器による患者診断のニーズの高さが、このセグメントの需要に寄与しています。

呼吸器疾患検査市場：地域別分析

呼吸器疾患検査市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。北米が世界の呼吸器疾患検査市場で大きなシェアを占めているのは、その先進的なヘルスケアインフラ、先進的な診断法の高い採用率、強力な研究開発投資によるものです。米国肺協会によると、2023年には約1,600万人の米国人がCOPDと診断されます。アジア太平洋地域は、患者人口の多さ、ヘルスケアインフラの改善、投資の増加により、呼吸器疾患検査市場で最も高い成長が見込まれています。中国やインドのような国々は、公害や喫煙などが原因で結核（TB）、COPD、その他の呼吸器感染症の罹患率が高いです。

呼吸器疾患検査市場：競合情勢

呼吸器疾患検査市場は競争が激しく、さまざまな診断ソリューションを提供する世界企業、地域企業、新興企業が存在します。競合は、先進的で正確かつ迅速な検査法へのニーズによって促進されています。新興国では、新興企業や中小企業が、携帯可能で費用対効果の高いソリューションを導入して技術革新に貢献しています。市場関係者は、結核や肺炎などの呼吸器感染症に対する微生物学的・分子生物学的診断法にも注力しています。各社は、ヘルスケアプロバイダーや患者の進化するニーズに応えるため、革新的な診断ソリューションを導入する研究開発に積極的に取り組んでいます。

目次

第1章 呼吸器疾患検査市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 呼吸器疾患検査の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 呼吸器疾患検査市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 呼吸器疾患検査市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 呼吸器疾患検査の市場情勢

  • 呼吸器疾患検査の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 呼吸器疾患検査市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 画像検査
    • 血液ガス検査
    • 呼吸測定装置
    • その他

第8章 呼吸器疾患検査市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 肺がん
    • 結核
    • 喘息
    • 慢性閉塞性肺疾患（COPD）
    • その他

第9章 呼吸器疾患検査市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • 臨床検査室
    • その他

第10章 呼吸器疾患検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：呼吸器疾患検査業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Becton, Dickinson and Company（BD）
    • bioMerieux SA
    • Quest Diagnostics Incorporated
    • Danaher Corporation
    • PerkinElmer Inc.
    • MGC Diagnostics Corporation
    • Oxford Nanopore
    • Agilent Technologies, Inc.
    • Vyaire Medical, Inc.
    • Philips Healthcare
    • GE HealthCare Technologies In
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4786

REPORT HIGHLIGHT

Respiratory Disease Testing Market size was valued at USD 6,590.43 Million in 2024, expanding at a CAGR of 2.99% from 2025 to 2032.

Respiratory disease testing is used in diagnostic procedures to detect, evaluate, and monitor diseases affecting the respiratory system, which includes the lungs, airways, and other structures involved in breathing. These tests help identify conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, tuberculosis, lung cancer, and infections like COVID-19 virus.

Respiratory Disease Testing Market- Market Dynamics

Growing prevalence of infectious respiratory diseases and rising digital integration are expected to propel market demand

The respiratory disease testing market has is expected to witness substantial growth due to a combination of factors, including the rising prevalence of respiratory illnesses, and technological advancements. Chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases are on the rise. According to the World Health Organization (WHO), COPD is among the leading causes of death worldwide, and asthma affects hundreds of millions worldwide. Further, rapid testing methods like RT-PCR became household terms, and diagnostic labs expanded their capacity.

Furthermore, New techniques, such as molecular diagnostics, polymerase chain reaction (PCR) tests, and next-generation sequencing (NGS), have improved the sensitivity and specificity of respiratory disease detection. The availability of portable and rapid diagnostic tools has made respiratory disease testing more accessible. These devices are particularly beneficial in remote areas and emergency scenarios. Artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic processes to enhance speed and accuracy. AI-powered tools are aiding in the interpretation of imaging tests like chest X-rays and CT scans. Moreover, high costs of advanced diagnostic tools and disparities in healthcare access, these issues have prompted innovations like telemedicine and low-cost testing solutions, further driving growth.

Respiratory Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.99% over the forecast period (2025-2032)

Based on Product segmentation, the imaging tests segment was predicted to show maximum market share in the year 2024, due to increased adoption of X-ray imaging.

Based on Application segmentation, the tuberculosis segment was the leading Application segment in 2024, due to high prevalence of tuberculosis and need for diagnosis.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2024, due to increasing adoption of advanced medical devices like X-ray machines.

On the basis of region, North America was the leading revenue generator in 2024, owing to high prevalence of asthma, and other respiratory diseases.

Respiratory Disease Testing Market- Segmentation Analysis:

The Global Respiratory Disease Testing Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into four categories based on Product: imaging tests, blood gas test, respiratory measurement devices, and others. The imaging tests segment dominates the market. High adoption of advanced imaging devices like X-ray machines and 3D imaging platforms are fueling segment growth.

The market is divided into five categories based on the Application: lung cancer, tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and others. The tuberculosis segment is expected to hold the largest share. The lung cancer segment is estimated to grow at the fastest rate during the forecast period, due to the need for preventive diagnosis care.

The market is divided into three categories based on End User: hospitals, clinical laboratories, and others. The hospitals segment holds the largest share in the End User segment. The growing prevalence of respiratory diseases, and high need for patient diagnosis with advanced devices is contributing to segment demand.

Respiratory Disease Testing Market- Geographical Insights

Across the world, the Respiratory Disease Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global respiratory disease testing market due to its advanced healthcare infrastructure, high adoption of advanced diagnostics, and strong R&D investments. According to the American Lung Association, approximately 16 million Americans are diagnosed with COPD in 2023. The Asia-Pacific region is expected to witness the highest growth in the respiratory disease testing market due to a large patient population, improving healthcare infrastructure, and increased investments. Countries like China and India have high rates of tuberculosis (TB), COPD, and other respiratory infections due to pollution, smoking, etc.

Respiratory Disease Testing Market- Competitive Landscape:

The respiratory disease testing market is highly competitive, with the presence of global, regional, and emerging players offering a range of diagnostic solutions. Competition is fueled by the need for advanced, accurate, and rapid testing methods. In emerging economies, startups and smaller firms are contributing to innovation by introducing portable and cost-effective solutions. Market players also focus on microbiology and molecular diagnostics for respiratory infections like tuberculosis and pneumonia. Companies are actively engaged in research and development to introduce innovative diagnostic solutions to meet the evolving needs of healthcare providers and patients.

Recent Developments:

In October 2024, Quest Diagnostics announced the launch of a test for the H5N1 bird flu, to enhance the company's portfolio.

In October 2024, Oxford Nanopore partnered with NHS England to expedite the screening of new pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY DISEASE TESTING MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Becton, Dickinson and Company (BD)
  • bioMerieux SA
  • Quest Diagnostics Incorporated
  • Danaher Corporation
  • PerkinElmer Inc.
  • MGC Diagnostics Corporation
  • Oxford Nanopore
  • Agilent Technologies, Inc.
  • Vyaire Medical, Inc.
  • Philips Healthcare
  • GE HealthCare Technologies Inc.
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Imaging tests
  • Blood gas test
  • Respiratory measurement devices
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Lung cancer
  • Tuberculosis
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinical Laboratories
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Disease Testing Market Snippet by Product
    • 2.1.2. Respiratory Disease Testing Market Snippet by Application
    • 2.1.3. Respiratory Disease Testing Market Snippet by End User
    • 2.1.4. Respiratory Disease Testing Market Snippet by Country
    • 2.1.5. Respiratory Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Disease Testing Key Market Trends

  • 3.1. Respiratory Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Disease Testing Market Opportunities
  • 3.4. Respiratory Disease Testing Market Future Trends

4. Respiratory Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Disease Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Respiratory Disease Testing Market Landscape

  • 6.1. Respiratory Disease Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Disease Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Imaging tests
    • 7.1.3. Blood gas test
    • 7.1.4. Respiratory measurement devices
    • 7.1.5. Others

8. Respiratory Disease Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Lung cancer
    • 8.1.3. Tuberculosis
    • 8.1.4. Asthma
    • 8.1.5. Chronic obstructive pulmonary disease (COPD)
    • 8.1.6. Others

9. Respiratory Disease Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Others

10. Respiratory Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Respiratory Disease Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Respiratory Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Respiratory Disease Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. F. Hoffmann-La Roche AG
    • 11.2.4. Siemens Healthineers
    • 11.2.5. Becton, Dickinson and Company (BD)
    • 11.2.6. bioMerieux SA
    • 11.2.7. Quest Diagnostics Incorporated
    • 11.2.8. Danaher Corporation
    • 11.2.9. PerkinElmer Inc.
    • 11.2.10. MGC Diagnostics Corporation
    • 11.2.11. Oxford Nanopore
    • 11.2.12. Agilent Technologies, Inc.
    • 11.2.13. Vyaire Medical, Inc.
    • 11.2.14. Philips Healthcare
    • 11.2.15. GE HealthCare Technologies In
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us